Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate
Open Access
- 1 April 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 99 (4) , 798-802
- https://doi.org/10.1111/j.1476-5381.1990.tb13009.x
Abstract
1 Neutrophils and eosinophils infiltrate the airways in association with the allergen-induced late phase asthmatic reaction. Mobilization of these cells takes place via lipid-like and protein-like chemotactic factors. In this study platelet-activating factor (PAF), leukotriene B4 (LTB4), zymosan-activated serum (ZAS) and N-formyl-methionyl-leucyl-phenylalanine (FMLP) were used as illustrative examples of both groups. Chemotaxis was studied in human neutrophils and eosinophils. The inhibitory effects of nedocromil sodium and sodium cromoglycate were evaluated. 2 All chemotactic factors tested attracted neutrophils with the following rank order of activity: ZAS > PAF ≡ FMLP ≡ LTB4. Eosinophils were only mobilized by PAF, LTB4 and ZAS with the following rank order of activity: ZAS > PAF > LTB4. 3 Nedocromil sodium and sodium cromoglycate were equally active as the PAF antagonist BN 52021 in inhibiting the PAF-induced chemotaxis of neutrophils (IC50 & 10−8 m). Both drugs were also equally active in inhibiting the chemotaxis of neutrophils induced by ZAS (IC50 ≅ 10−7−10−6 m), FMLP(IC50 ≅ 10−7 m) and LTB4 (IC50 ≅ 10−6 m). 4 Nedocromil sodium significantly inhibited the chemotaxis of eosinophils induced by PAF (IC50 ≅ 10−6 m) and LTB4 (IC50 ≅ 10−7 m). The inhibitory potency of BN 52021 was similar to that of nedocromil sodium on the PAF-induced chemotaxis of eosinophils. Sodium cromoglycate was incapable of eliciting significant inhibition of these chemotactic responses. However, sodium cromoglycate significantly inhibited the chemotaxis of eosinophils induced by ZAS (IC50 ≅ 10−7 m), whereas nedocromil sodium was ineffective.This publication has 25 references indexed in Scilit:
- Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycateBritish Journal of Pharmacology, 1989
- 159 The ginkgolide (BN 52021) inhibits PAF-induced chemotaxis and specific binding to human eosinophils and neutrophilsJournal of Allergy and Clinical Immunology, 1988
- Cromolyn inhibition of protein kinase C activityBiochemical Pharmacology, 1987
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- Eosinophils, bronchial hyperreactivity and late‐phase asthmatic reactionsClinical and Experimental Allergy, 1985
- Late asthmatic responses: Inquiry into mechanisms and significanceClinical Reviews in Allergy, 1985
- Selective transduction of human polymorphonuclear leukocyte functions by subsets of receptors for leukotriene B4Journal of Allergy and Clinical Immunology, 1984
- Specific leukotriene formation by purified human eosinophils and neutrophilsFEBS Letters, 1984
- Effects of Novel Lipoxygenase Products on Migration of Eosinophils and Neutrophils in vitroInternational Archives of Allergy and Immunology, 1983
- Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.Journal of Clinical Investigation, 1975